Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity | Zendy

Ayumi Yoshizaki | Zendy; Kazuhiro Komura | Zendy; Yohei Iwata | Zendy; Fumihide Ogawa | Zendy; Toshihide Hara | Zendy; Eiji Muroi | Zendy; Motoi Takenaka | Zendy; Kazuhiro Shimizu | Zendy; Minoru Hasegawa | Zendy; Manabu Fujimoto | Zendy; Shinichi Sato | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity

Author(s) -

Ayumi Yoshizaki,

Kazuhiro Komura,

Yohei Iwata,

Fumihide Ogawa,

Toshihide Hara,

Eiji Muroi,

Motoi Takenaka,

Kazuhiro Shimizu,

Minoru Hasegawa,

Manabu Fujimoto,

Shinichi Sato

Publication year - 2008

Publication title -

journal of clinical immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.739

H-Index - 96

eISSN - 1573-2592

pISSN - 0271-9142

DOI - 10.1007/s10875-008-9252-x

Subject(s) - medicine , rage (emotion) , immune system , scleroderma (fungus) , disease , immunology , biology , neuroscience , inoculation

The high mobility group box 1 protein (HMGB-1)/advanced glycation end products (RAGE) system is recently shown to play an important part in immune/inflammatory disorders. However, the association of this system in systemic sclerosis (SSc) remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research